C
ETNB

Covestor’s 89bio ETNB Stock Holding History

Covestor’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,347
Closed -$314K – 2381
2025
Q3 		$314K Buy
21,347
+21,336
+193,964% +$217K 0.17% 71
2025
Q2 		$0 Sell
11
-1
-8% -$8 ﹤0.01% 2347
2025
Q1 		$0 Hold
12
– – ﹤0.01% 2359
2024
Q4 		$0 Buy
12
+1
+9% +$8 ﹤0.01% 2365
2024
Q3 		$0 Sell
11
-1
-8% -$8 ﹤0.01% 2356
2024
Q2 		$0 Hold
12
– – ﹤0.01% 2368
2024
Q1 		$0 Hold
12
– – ﹤0.01% 2366
2023
Q4 		$0 Buy
12
+5
+71% +$46 ﹤0.01% 2282
2023
Q3 		$0 Buy
+7
New +$118 ﹤0.01% 2258

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Covestor's ETNB Position: Q4 2025 in Review

Covestor sold out of 89bio (ETNB) in Q4 2025, closing a stake of 21,347 shares — an estimated $314K sold.

Covestor first reported a position in ETNB in Q3 2023 and held it in 9 quarters. The position peaked at $314K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Covestor reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Covestor sold 21,347 89bio shares in Q4 2025, an estimated $314K.
  • Covestor first reported a position in 89bio in Q3 2023 and held it in 9 quarters.
  • Covestor's 89bio position peaked at $314K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Covestor's 13F filing for Q4 2025, filed 6 Feb 2026.